Abaloparatide(brand nameTymlos; formerlyBA058) is a bone-growing prescription medication given by subcutaneous injection that was approved in April 2017 by the Food and Drug Administration (FDA) for reducing fracture risk. During animal drug testing, TYMLOS caused some rats to develop a bone cance...